Patient Reminder Card

This page provides patient reminder cards for denosumab, an active substance used in the treatment of certain medical conditions. These cards are designed to help you remember important information about your treatment and to support the safe and effective use of your medication.

To access the reminder card specific to your country and in your local language, please select your country from the dropdown menu. You will then be able to download the PDF version of the reminder card.

Disclaimer

These patient reminder cards are provided in accordance with regulatory requirements and have been approved by the relevant health authorities in each country. The information contained in the cards is intended solely for patients who have been prescribed denosumab by their healthcare professional. If you have not been prescribed denosumab, please do not download or use these materials. Always consult your doctor or pharmacist if you have any questions about your treatment.

Country Dosage
60 mg 120 mg
Spain Tarjeta de información para el paciente denosumab 60 mg -
Italy Carta per il paziente denosumab 60 mg Carta per il paziente denosumab 120 mg
Croatia Kartica podsjetnik denosumab 60 mg Kartica podsjetnik denosumab 120 mg
Poland Karta przypominająca denosumabem 60 mg -
Denmark Patientkort denosumab 60 mg Patientkort denosumab 120 mg
Hungary Betegkártya denoszumab 60 mg -
Netherlands Herinneringskaart voor patiënten denosumab 60 mg Herinneringskaart voor patiënten denosumab 120 mg
Sweden Påminnelsekort för patienten denosumab 60 mg Påminnelsekort för patienten denosumab 120 mg
Romania - Card de reamintire pentru pacient denosumab 120 mg
Austria Erinnerungskarte denosumab 60 mg -
Germany Erinnerungskarte denosumab 60 mg Erinnerungskarte denosumab 120 mg
Norway Pasientminnekort denosumab 60 mg Pasientminnekort denosumab 120 mg
United Kingdom Reminder card denosumab 60 mg Reminder card denosumab 120 mg
Finland Potilaan muistutuskortti denosumabi 60 mg
Påminnelsekort för patienten denosumab 600 mg 		Potilaan muistutuskortti denosumabi 120 mg
Påminnelsekort för patienten denosumab 120 mg

Below you can access the Summaries of Product Characteristics (SmPCs) for IZAMBY® and DEMBRAYCE®, as approved in the European Union. These documents provide essential information for healthcare professionals regarding the authorised use of both products, including therapeutic indications, dosage, contraindications and safety profile, in accordance with applicable regulatory requirements.

IZAMBY®: https://ec.europa.eu/health/documents/community-register/html/h1935.htm
DEMBRAYCE®: https://ec.europa.eu/health/documents/community-register/html/h1936.htm
Union Register of medicinal products – Public health – European Commission
Union Register of medicinal products